“…In addition, in vivo blockade of PDGF-BB or PDGFR- reduces SMC migration into neointimal lesions after vascular injury and decreases SMC accumulation and fibrous cap formation within developing atherosclerotic plaques in mice (25,37,54,66,69). Recent studies have demonstrated that PDGF-DD, a newly discovered PDGF isoform that is a more selective agonist of the PDGFR-, also promotes SMC phenotypic modulation through repressing SMC differentiation marker gene expression and increasing SMC proliferation and migration (5,13,38,73). Genetic deletion of the PDGFR- in cultured SMCs abrogated PDGF-DD-and PDGF-BB-induced repression of SMC differentiation marker genes, suggesting that these effects of PDGF on SMC phenotype are mediated via PDGFR- activation (73).…”